Navigation Links
Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
Date:5/28/2008

- Internationally Recognized Oncologists Will Offer Strategic Guidance on

Picoplatin Clinical Development -

SOUTH SAN FRANCISCO, Calif., May 28 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced the appointment of four additional members to its Clinical Advisory Board to help guide the Company's expanding clinical development strategy for picoplatin. They include Howard A. Burris, III, M.D., of The Sarah Cannon Research Institute in Nashville; E. David Crawford, M.D., of the University of Colorado Comprehensive Cancer Center; Robert F. Ozols, M.D., Ph.D., of the Fox Chase Cancer Center in Philadelphia; and Everett E. Vokes, M.D., of the University of Chicago Pritzker School of Medicine.

These esteemed physicians will add to the already broad expertise of the Company's Clinical Advisory Board and bring an understanding of a wide variety of tumor types, including prostate, breast, ovarian, head and neck and lung cancers, to inform the development of picoplatin. Picoplatin, the Company's lead product candidate, is a new generation platinum chemotherapy agent with the potential to address multiple indications, combinations and formulations.

"These renowned physicians are experts in several different indications and will provide strategic input into our clinical development program for picoplatin, which is being developed as a platform product with broad applicability across multiple solid tumor types," said Robert De Jager, M.D., chief medical officer of Poniard.

The new Clinical Advisory Board members join existing members Paul J. Bunn, Jr., M.D., of the University of Colorado Comprehensive Cancer Center; Alan
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
2. Poniard Pharmaceuticals Announces Upcoming Conference Participation
3. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
4. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
5. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
6. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
7. XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
8. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
9. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
10. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
11. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Stallergenes has been,g...oth adults and children,through a Mutual Recogniti...lair(R) has been marketed, was the reference Membe...n Austria, Belgium, Bulgaria, Cyprus, the,Czech Re... Ireland, Italy,Latvia, Lithuania, Luxembourg, Ma...
(Date:11/26/2009)... generation of ultrasmall transistors and more pow...semiconducting nanowires are closer to reality aft...niversity and the University of California at Los ...reate nanowires with layers of different materials...ch is a critical requirement for making efficient ...
(Date:11/25/2009)... Biotech firm Replikins Ltd., which...e 1918 pandemic through the prediction, outbreak, ...ssued its latest biochemical analysis of the virus...1 ("Swine Flu") virus has dropped from its peak of...k in the spring of 2009 to resting non-epidemic le...
(Date:11/25/2009)..., BOCA RATON, Fla., Nov. 25 For ... so for BodyLogicMD. The nation,s largest and fas...zing exclusively in medically supervised bioident...ans in its network since November 2008 - from 2...re physician-owned centers, including one in Puert...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4
...rt(R)-Based Test to Assess Genetic Risk of Thrombo...ys Associated with Batch Processing, SUNNYVALE, C...irstCall/,-- Cepheid (Nasdaq: CPHD ) and Instrume...stics company, today announced the release of the ... CE IVD Mark product under the,European Directive ...
...Feb. 25 Newly published data by Dr. J.,Barthelow ...y to cause,diabetes in children with a strong fami... papers provided proof that vaccines cause diabete...eir benefit in the general,population. New data in...ith a strong family history of diabetes. For examp...
...Feb. 25 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX...ief Medical,Officer and Executive Vice President o...d of Directors. In connection with Dr. Rowinsky,s ...rd from six to seven directors., "We are delighte...ings,tremendous knowledge and expertise within the...
Other Biology Technology:Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 2Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 3Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 4Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 5Eric K. Rowinsky Joins ADVENTRX Board of Directors 2Eric K. Rowinsky Joins ADVENTRX Board of Directors 3Eric K. Rowinsky Joins ADVENTRX Board of Directors 4
(Date:11/26/2009)...ht European countries has shown that closing schoo...could have a significant role in reducing illness ...ss journal BMC Infectious Diseases compared oppo...s/holidays, finding that they were reduced when sc...twerp University, Belgium, led a team of European ...
(Date:11/25/2009)... in the stomach, may be used to boost resistance t..., Yale School of Medicine researchers report in a ...of Neuroscience . , Parkinson,s disease is cause... of the midbrain known as the substantia nigra, wh...ed production of dopamine in late-stage Parkinson,...
(Date:11/25/2009)...me, the heart pumps some 250 million liters of blo...muscle fibers of the heart have to be extremely du...ottbauer, vice chair of the Department of Medicine...Prof. Dr. H. A. Katus), has discovered a protein t...st muscular unit, the sarcomere. In cooperation wi...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 1CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 3IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 1IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 2Involving family in medical rounds benefits both family and medical team 62042 1Involving family in medical rounds benefits both family and medical team 62042 2Involving family in medical rounds benefits both family and medical team 62042 3Involving family in medical rounds benefits both family and medical team 62042 4
...dies of the birth and incorporation of neurons int...dult neurogenesispromise intriguing insights into ...he causes of depression and other psychiatric diso...ory Press ( www.cshlpress.com ) helps to define th... ( http://www.cshlpress.com/link/adultneuro.htm ) ...
... of world-leading scientists including those who ...rown at a parasitic worm less than 1mm long. , T...attacks potato crops all over the world and is par...e the potato is a subsistence crop. A 1.7 million ...quence its DNA, hopes to shed light on the mechani...
...ree of Life for flowering plants has been revealed...hese plants to date, report scientists from The Un...ida. , The scientists, publishing two papers in P...s week online, found that the two largest groups o...latives) and eudicots (including sunflowers and to...
Other Biology News:New book defines promising young field of adult neurogenesis 2New research to decode the genetic secrets of prolific potato pest 2Tree of life for flowering plants reveals relationships among major groups 2
Rabbit Anti-b-Catenin, phospho (Ser675) Antibody, Unconjugated from Spring Bioscience
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Anti-NSP-C (Neuroendocrine-Specific-Protein) Monoclonal Antibody, Unconjugated, Clone RNL-4 from CHEMICON
Anti-Integrin alpha6beta1 (VLA6) Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: